EcoDrugPlus

Potassium Voltage-Gated Channel Subfamily Q Member 5

Ensembl ID : ENSLOCG00000016173
Gene Symbol: KCNQ5
3 Cross references
278 Possible Orthologues:

Presenilin 1

Ensembl ID : ENSLOCG00000013357
Gene Symbol: PSEN1
3 Cross references
200 Possible Orthologues:

Progesterone Receptor

Ensembl ID : ENSLOCG00000005538
Gene Symbol: PGR
3 Cross references
193 Possible Orthologues:

Prostaglandin D2 Receptor

Ensembl ID : ENSLOCG00000012020
Gene Symbol: PTGDR
4 Cross references
118 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSLOCG00000018087
Gene Symbol: PTGDR2
4 Cross references
145 Possible Orthologues:

Prostaglandin D2 Receptor 2-Like

Ensembl ID : ENSLOCG00000013246
Gene Symbol: LOC102693478
2 Cross references
135 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSLOCG00000010015
Gene Symbol: PTGER3
3 Cross references
195 Possible Orthologues:

Prostaglandin E Receptor 4

Ensembl ID : ENSLOCG00000011237
Gene Symbol: PTGER4
3 Cross references
274 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype-Like

Ensembl ID : ENSLOCG00000008504
Gene Symbol: LOC102696570
3 Cross references
235 Possible Orthologues:

Prostaglandin E2 Receptor Ep2 Subtype-Like

Ensembl ID : ENSLOCG00000012035
Gene Symbol: LOC102698281
3 Cross references
202 Possible Orthologues:

Prostaglandin F Receptor

Ensembl ID : ENSLOCG00000003835
Gene Symbol: PTGFR
3 Cross references
195 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSLOCG00000014873
Gene Symbol: PTGIR
3 Cross references
187 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).